Información del producto
CMPDA is a monoclonal antibody that binds to activated dasatinib, which is an epidermal growth factor receptor tyrosine kinase inhibitor. CMPDA blocks the binding of dasatinib and other therapeutic agents to their receptor targets, thereby inhibiting cancer cell growth. In addition, it has been shown to reduce inflammation in mouse models of inflammatory bowel disease. CMPDA also inhibits angiogenesis by binding to the erythropoietin receptor and blocking the production of vascular endothelial growth factor (VEGF). This agent has been shown to have a strong inhibitory effect on fungal biomass.
Propiedades químicas
Consulta técnica sobre: 3D-FQA60777 CMPDA
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
